Bronchiectasis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Bronchiectasis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : October, 2022 | Pharmaceutical

Report Digest


Bronchiectasis refers to a lung condition in which the walls of the bronchi are thickened owing to severe damage to the bronchi tissues. The bronchiectasis disease ranks on top of the list of respiratory diseases worldwide. 

The bronchiectasis drugs market around has been growing at a rapid pace over the years because of factors such as the high presence of bronchiectasis among the public and better infrastructure facilities in the healthcare and medical sector. Experts believe that constant research and development in the field and rising competition among established drug makers will help maintain a high growth rate for the bronchiectasis drugs market.

Antibiotics and expectorants are the main types of drugs available in the bronchiectasis drugs market. Among them, the antibiotic segment has the greater demand and is anticipated to continue to stay ahead of the expectorant segment in the coming few years. An increase in the number of respiratory diseases has been driving the antibiotics demand. In addition, the low costs and easy availability of these antibiotics have helped the demand substantially, as well.

The bronchiectasis drugs market has been divided into five regions globally: Europe, Asia Pacific, Latin America, North America, and Middle East and Africa. North America has been the leader in the bronchiectasis drugs market because of the high presence of bronchiectasis and other respiratory disorders among the public, in this region. Experts believe that due to the increasing usage of off-label antibiotic drugs, the bronchiectasis drugs market in North America will remain on top for the next few years.

The ever-increasing geriatric population in North America, who are prone to respiratory diseases is enhancing the growth of the bronchiectasis drugs market significantly. Asia Pacific is also witnessing a reasonable growth in the bronchiectasis drugs market due to rising awareness among the public about the initial symptoms of bronchiectasis.

Global Bronchiectasis Drugs Market: Introduction

The alarming rise in pollution across the world has given rise to a number of respiratory diseases, among which bronchiectasis occupies the top position. Together with the infrastructural improvements in the medical and healthcare sector, the high prevalence of bronchiectasis and other respiratory disorders among consumers has kept the global bronchiectasis drugs market soaring over the years. With continuous research and development in this field and increasing competition among leading drug makers, experts believe this market will manage to retain a high growth rate over the forthcoming years.

This research report offers a detailed and insightful assessment of the global bronchiectasis drugs market, taking primary trends and the future prospects of this market in consideration. Various segments of this market, based on a number of parameters, have also been evaluated to gain a clear overview of the dynamics in the worldwide bronchiectasis drugs market.

Global Bronchiectasis Drugs Market: Notable Developments

Hitherto, there is no commercial product for bronchiectasis. The leading pharmaceutical companies, such as Santhera Pharmaceuticals Holding AG, Bayer AG, and Insmed Inc., are actively seeking approvals for their drugs to accelerate the development process. Companies, involved in developing drugs for bronchiectasis, have been showing positive results in various drug development phases.

  • Bayer AG recently gained approval from the U.S. FDA for their Ciprofloxacin dry powder. The U.S. FDA has granted orphan drug designation to this inhalation drug.
  • Insmed Inc. showcased its topline results for the third phase of the testing of Amikacin Liposome Inhalation Suspension (ALIS) in adults suffering from respiratory diseases caused by mycobacterium, especially bronchiectasis.

Some of the most prominent competitors operating in the competitive landscape of global bronchiectasis drugs market include –

  • Aradigm Corp.
  • Zambon S.p.A.
  • Endo International Plc.
  • Alitair Pharmaceuticals Inc.
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Neopharma LLC,
  • Reckitt Benckiser Group Plc.

Global Bronchiectasis Drugs Market: Market Dynamics

High Prevalence of Respiratory Disorders Reflects on Demand for Antibiotics

Antibiotics and expectorants are the primary types of drugs available in the global bronchiectasis drugs market. Among the two, the antibiotics segment has recorded the lead and is expected to continue doing so over the next few years. The upswing in the prevalence of various respiratory disorders and infections has been driving the demand for antibiotics, reflecting on the growth of this segment. The easy availability and low cost of antibiotics is adding to their demand significantly. However, the expectorants segment will also gain momentum in the years to come.

North America to Retain Top Position in Global Bronchiectasis Drugs Market

The global bronchiectasis drugs market is spread across Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. North America, among these, has acquired the leading position on the back of the high prevalence of bronchiectasis and several other respiratory disorders among people. Experts believe this regional market will be able to retain its position over the next few years, thanks to the rising usage of off-label anti-biotic drugs. The ever-rising geriatric population base, which is prone to respiratory disorders, is also supporting the growth of the North America bronchiectasis drugs market substantially. Asia Pacific is also witnessing a decent rise in its bronchiectasis drugs market, thanks to the increasing awareness among people regarding the early symptoms of bronchiectasis and its treatments. 

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.

5-Point Growth Formula

The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.

The 5-point growth formula includes the following points:

  • Current and Future Threats
  • Accurate Trend Analysis
  • Regional Assessment
  • Industrial Analogy
  • COVID-19 Impact

Current and Future Threats

Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.

Accurate Trend Analysis

Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.

Regional Assessment

Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.

Industrial Analogy

The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.

COVID-19 Impact

The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.